Navigation Links
URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs
Date:1/24/2008

New pharmacy accreditation standards for Specialty Pharmacy, Workers Compensation and Mail Service Pharmacy

WASHINGTON, Jan. 24 /PRNewswire-USNewswire/ -- URAC called for public comment today on three new pharmacy accreditation programs. The programs are Specialty Pharmacy, Mail Service Pharmacy and Pharmacy Benefit Management (PBM) for Workers Compensation and Property and Casualty. The new programs closely follow URAC's groundbreaking Pharmacy Benefit Management Accreditation standards released in July 2007, the only third-party, voluntary accreditation program for the pharmacy benefit management industry. URAC is seeking comments from a broad range of stakeholders, including employers, consumers, purchasers, providers, regulators, and the pharmacy benefits management industry. The deadline for public comment is March 6, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO )

The standards were developed by URAC's Pharmacy Benefits Management Advisory Committee, which includes a wide range of stakeholders: employers, consumers, pharmacy consultants, health plans, independent retail pharmacy, pharmacy benefits management organizations, pharmacy professional organizations, labor, and large public purchasing groups.

"These accreditation programs build on the success of URAC's initial Pharmacy Benefit Management program, bringing an emphasis on continuous quality improvement and on consumer education and empowerment to the industry," said Alan P. Spielman, URAC's president and chief executive officer. "We welcome and invite broad input from consumers, purchasers, providers, regulators, and the industry on the draft standards."

The Specialty Pharmacy and Mail Service Pharmacy accreditations are for organizations involved in the hands-on delivery of these pharmacy services. Specialty pharmacy organizations offer a high touch,
'/>"/>

SOURCE URAC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. NIH panel seeks to dispel stigma associated with fecal and urinary incontinence
2. Group Seeks Refinement of Knee Arthritis Treatment Guidelines
3. The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off States Existing Six-Year Surcharge Period
4. Leading neuroscientist seeks beauty, love and happiness
5. American Cancer Society Seeks Volunteers to Help Decide Who Gets Research Grants
6. FDA Seeks Food Recall Authority
7. Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages
8. New Legislation Seeks to Improve Access to Community Mental Healthcare
9. amfARs MSM Initiative Seeks Proposals From Front-Line Groups Working on HIV in Developing Countries
10. Drug Industry Seeks Tests to Spot Side Effect Risks
11. OSHA Seeks Input from Stakeholders on Diacetyl and Food Flavorings Containing Diacetyl
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...J., Dec. 2 Cantel Medica... to discuss the Company,s results for its first qu...t 11:00 AM ET. Participating in the call will be ...esident; Craig A. Sheldon, Senior Vice President a...orporation. Minntech is a Cantel subsidiary. The f...
(Date:12/2/2008)... Ingenious Med (IM) welcomes new CE...der in inpatient practice,management solutions, w...are,software, revenue management, medical servic... nine-year CEO, Dr. Steven Liu, is confident Willi...opment in all sectors, as he steps into,the role....
(Date:12/2/2008)...moms who took it in first 3 months more likely to ...2 (HealthDay News) -- Infants whose mothers take f... an increased risk for respiratory illness, accord...ed to reduce the risk of birth defects, and many c... The researchers examined data on more than 32,000...
(Date:12/2/2008)... researchers at The University of Nottingham has i...cancer. , The research, published in the journal..., USA and funded by a 72,000 grant from the Britis...essor gene, LIMD1, is responsible for protecting t...y for possible new treatments and early screening ...
Breaking Medicine News(10 mins):Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008 2Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2Health News:Gene which protects against lung cancer identified 2
...of developing pancreatic cancer increases by 90% w... // Pancreatic cancer risk was 70% higher in peopl...times a day when compared with those who added no ...r intake been already considered as a risk factor,...
...p of hospital services in east Lancashire by a cou...ers. // East Lancashire Hospitals NHS Trust has ... of Burnley's A&E department that will now not be ...the overview and scrutiny by the council’s committ...
...nother anti-polio drive Sunday even as new polio c... detected. During the drive, pulse polio drops wo...of up to five years of age, according to health of...case of polio was confirmed by the National Polio ...
...al Of American Medical Association announced that ... might not be completely bad. In fact a theory by ...as brought the association of heart attach and hig...r. Gheorghiade through his research found that dur...
Other Medicine News:Health News:Fury over Backing of Health Shake-up 2
(Date:11/25/2008)...nst expanding statin use broadly in wake of AHA-pr...25 JUPITER, a clinical trial sugge...sk of healthy patients with elevated CRP, should n...cording to a national poll directed at health prof...e online poll conducted by medical news site MedPa...
(Date:11/25/2008)... Poniard,Pharmaceutical...pany focused on,innovative oncology therapies, an... alternatives for its preclinical research program...urces on the clinical development of picoplatin,...tial commercialization of,picoplatin in the treat...
(Date:11/25/2008)...ial to Assess Survival of Patients Receiving Litx ... Hepatocellular Carcinoma , , BELLEVUE, Was...y, Inc. (LSO) today announced the completion of en...ht Infusion Therapy(TM) (Litx(TM)) as a treatment ...lso known as hepatoma or primary liver cancer. , ...
(Date:11/24/2008)...ov. 24 Takeda Pharmaceutical Compa... Global Research & Development Center, Inc., U...ommittee of the U.S. Food and Drug Administration ... for the treatment of hyperuricemia in patients wi...val, with one panel member abstaining. The vote fo...
Breaking Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Biophysical Society names 2009 award recipients 4751 1Biophysical Society names 2009 award recipients 4751 2Leaders in Pathology Meet in San Diego 3A Sept 25 28 2008 26107 1Leaders in Pathology Meet in San Diego 3A Sept 25 28 2008 26107 2HRSA Announces 2439 Million in Grants to Expand Improve Health Center Services 26105 1HRSA Announces 2439 Million in Grants to Expand Improve Health Center Services 26105 2Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year 7513 1Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year 7513 2
...pr 10, 2007 - Valeant,Pharmaceuticals Internationa...ase 2 data for retigabine, a first-in-class,neuron...ng,independent, scientific journal. The authors co...onstrated reduction in monthly,seizure rates in th... RESTORE2) are currently underway to further inves...
...es Insulin-Free, WASHINGTON, April 10, 2007 /PRNew...lt stem cell therapy, the Journal of the,American ...in which,14 of 15 Juvenile Diabetes patients demon...adult stem cell treatment. According,to U.S. Rep. ... in,that it,s the first attempt at using stem cell...
Other Medicine Technology:Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 2Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 3Newest Adult Stem Therapy Treats Diabetes 2
Wilbrandt-binkhorst irrigating cannula.
Binkhorst, length 18 mm.
Wilbrandt-Binkhorst Cannula have a smooth blunt tip end opening.
Army navy retractor set.
Medicine Products: